The New Role of SGLT2 Inhibitors in the Management of Heart Failure: Current Evidence and Future Perspective

• Główni autorzy: Saverio Muscoli (Autor), Francesco Barillà (Autor), Rojin Tajmir (Autor), Marco Meloni (Autor), David Della Morte (Autor), Alfonso Bellia (Autor), Nicola Di Daniele (Autor), Davide Lauro (Autor), Aikaterini Andreadi (Autor)
• Format: Książka
• Wydane: MDPI AG, 2022-08-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

The sodium-glucose transporter 2 inhibitors (SGLT2i) are a relatively new class of medication used in the management of type 2 diabetes. Recent clinical trials and research have demonstrated this class's effectiveness in treating heart failure, since they reduce the risk of cardiovascular event...